Clinical trial
Psma Intensity Can be Altered by Androgen and Phospho-SrC Obstruction
NCT04925648
Study timeline
Study start (actual)2021-10-18Date precision: day
Registry last updated2026-04-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Prostate Cancerunresolved
Interventions
DasatinibDRUG · verified · RxNorm: dasatinib
DarolutamideDRUG · verified · RxNorm: darolutamide
Sponsors & collaborators
St Vincent's Hospital, Sydneylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04925648 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.